ASBPW
Aspire Biopharma Holdings, Inc.
Key Financials
Gross Profit
$-116
N/A
Operating Income
$-19351291
↓ 1498.1%
Total Assets
$1.3M
↓ 80.5%
EPS (Diluted)
$-16.38
↓ 762.1%
Net Income
$-24480848
↓ 95.3%
Revenue
$6202
N/A
Shareholders' Equity
$-6376329.00
↑ 59.0%
Operating Cash Flow
$-4923488.00
↓ 139.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ASBPW |
| Company Name | Aspire Biopharma Holdings, Inc. |
| CIK | 1847345 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | E9 |
| Phone | 561-704-8527 |